Overexpression of c-Myc oncoprotein in oral squamous cell carcinoma in the south Indian population

ecancermedicalscience

Volumn 3, Issue 1, 2009, Pages

  Pai, R B ^a   Pai, S B ^a,b   Lalitha, R M ^a,c   Kumaraswamy, S V ^a,d   Lalitha, N ^a   Johnston, R N ^e   Bhargava, M K ^a  

^a KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY   (India)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^c M S RAMAIAH UNIVERSITY OF APPLIED SCIENCES   (India)

^d VS Dental College and Hospital ^*  (India)

^e UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BETEL NUT; CARCINOGENESIS; CHEEK MUCOSA; CLINICAL ARTICLE; DIET; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; INDIA; MALE; MOLECULAR DYNAMICS; MOUTH CANCER; ONCOGENE C MYC; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TOBACCO;

EID: 77956038869     PISSN: None     EISSN: 17546605     Source Type: Journal    
DOI: 10.3332/ecancer.2008.128     Document Type: Article

References (26)

1. Gupta PC, Warnakulasuriya S. Global epidemiology of areca nut usage. Addict Biol.2002;7:77-83.
2. Nair U, Bartsch H, Nair J. Alert for an epidemic of oral cancer due to use of the betel quid substitutes gutkha and pan masala: a review of agents and causative mechanisms. Mutagenesis.2004;19:251-262.
3. Chen CL, Chi CW, Liu TY. Hydroxyl radical formation and oxidative DNA damage induced by areca quid in vivo. J Toxicol Environ Health A.2002;65:327-336.
4. Jeng JH, Chang MC, Hahn LJ. Role of areca nut in betel quid-associated chemical carcinogenesis: current awareness and future perspectives. Oral Oncol.2001;37:477-492.
5. Gangane N, Chawla S, Anshu, Gupta SS, Sharma SM. Reassessment of risk factors for oral cancer. Asian Pac J Cancer Prev.2007;8:243-248.
6. Goessel G, Quante M, Hahn WC, Harada H, Heeg S, Suliman Y, Doebele M, von Werder A, Fulda C, Nakagawa H, Rustgi AK, Blum HE, Opitz OG. Creating oral squamous cancer cells: a cellular model of oral-esophageal carcinogenesis. Proc Natl Acad Sci U S A.2005;102:15599-15604.
7. Eilers M, Eisenman RN. Myc's broad reach. Genes Dev.2008;22:2755-2766.
8. Saranath D, Bhoite LT, Deo MG. Molecular lesions in human oral cancer: the Indian scene. Eur J Cancer B Oral Oncol.1993;29B:107-112.
9. Sugerman PB, Joseph BK, Savage NW. Review article: The role of oncogenes, tumour suppressor genes and growth factors in oral squamous cell carcinoma: a case of apoptosis versus proliferation. Oral Dis.1995; 1:172-188.
10. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW. Specific association of human telomerase activity with immortal cells and cancer. Science.1994;266:2011-2015.
11. Pai RB, Pai SB, Kukhanova M, Dutschman GE, Guo X, Cheng YC. Telomerase from human leukaemia cells: properties and its interaction with deoxynucleoside analogues. Cancer Res.1998;58:1909-1913.
12. Dwyer J, Li H, Xu D, Liu JP. Transcriptional regulation of telomerase activity: roles of the Ets transcription factor family. Ann N Y Acad Sci.2007;1114:36-47.
13. Lo Muzio L. A possible role for the WNT-1 pathway in oral carcinogenesis. Crit Rev Oral Biol Med.2001;12:152-165.
14. Miyashita H, Mori S, Motegi K, Fukumoto M, Uchida T. Pin1 is overexpressed in oral squamous cell carcinoma and its levels correlate with cyclin D1 overexpression. Oncol Rep.2003;10:455-461.
15. Chen YJ, Lin SC, Kao T, Chang CS, Hong PS, Shieh TM, Chang KW. Genome-wide profiling of oral squamous cell carcinoma. J Pathol.2004;204:326- 332.
16. Pai SB, Pai RB, Johnston RN. Overexpression of c-myc by amplification of negative promoter domain. J Biol Chem.1992;267:12428-12431.
17. Ponzielli R, Katz S, Barsyte-Lovejoy D, Penn LZ. Cancer therapeutics: targeting the dark side of Myc. Eur J Cancer.2005;41:2485-2501.
18. Pai SB, Pai RB, Lalitha RM, Kumaraswamy SV, Lalitha N, Johnston RN, Bhargava MK. Expression of oncofoetal marker carcinoembryonic antigen in oral cancers in South India--a pilot study. Int J Oral Maxillofac Surg.2006;35:746-749.
19. Eversole LR, Sapp JP. c-myc oncoprotein expression in oral precancerous and early cancerous lesions. Eur J Cancer B Oral Oncol.1993;29B:131-135.
20. Field JK. Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck. Eur J Cancer B Oral Oncol.1992;28B:67-76.
21. Field JK, Spandidos DA, Stell PM, Vaughan ED, Evan GI, Moore JP. Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma. Oncogene.1989;4:1463-1468.
22. Leonard JH, Kearsley JH, Chenevix-Trench G, Hayward NK. Analysis of gene amplification in head-and-neck squamous-cell carcinoma. Int J Cancer.1991;48:511-515.
23. Mishra R, Das BR. Early overexpression of Cdk4 and possible role of KRF and c-myc in chewing tobacco mediated oral cancer development. Mol Biol Rep.2003;30:207-213.
24. Baral R, Patnaik S, Das BR. Co-overexpression of p53 and c-myc proteins linked with advanced stages of betel- and tobacco-related oral squamous cell carcinomas from eastern India. Eur J Oral Sci.1998;106:907-913.
25. de Rosa I, Staibano S, Lo Muzio L, Delfino M, Lucariello A, Coppola A, De Rosa G, Scully C. Potentially malignant and malignant lesions of the lip. Role of silver staining nucleolar organizer regions, proliferating cell nuclear antigen, p53, and c-myc in differentiation and prognosis. J Oral Pathol Med.1999;28:252-258.
26. Scionti I, Michelacci F, Pasello M, Hattinger CM, Alberghini M, Manara MC, Bacci G, Ferrari S, Scotlandi K, Picci P, Serra M. Clinical impact of the methotrexate resistance-associated genes C-MYC and dihydrofolate reductase (DHFR) in high-grade osteosarcoma. Ann Oncol.2008;19:1500-1508.